By Malcolm Cunningham
There is no doubt that the growth in drug manufacturing using high potency active pharmaceutical ingredients (APIs) and the demand for aseptic processing has led to the development of exciting new transfer methods. But which methods are most prominent in the industry today? And what are the key challenges facing pharmaceutical businesses?
The market today
It is expected that the global contract pharma manufacturing market will reach an impressive $79.24bn next year, and this figure is only expected to rise over the next decade.